In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to reflect on the essential role of laboratory medicine during National Medical Laboratory Professionals Week. Dr. Pritt also welcomes Julia Lehman, M.D., a dermatologist and dermatopathologist at Mayo Clinic, to discuss innovative diagnostic tests for autoimmune diseases affecting the skin.

• Laboratory medicine’s expanding role (00:15): Learn how laboratory medicine touches nearly every aspect of healthcare — and why its importance will continue to grow with the integration of AI.
• An inspiring patient story (05:22): Hear how a young patient with a rare disease is able to pursue her passion for dance thanks to advances in laboratory medicine.
• Advances in testing for autoimmune blistering diseases (07:29): Discover how novel diagnostic tests are helping clinicians better tailor treatment for patients with complex skin conditions.

Note: Information in this post was accurate at the time of its posting.

Resources

• Immunodermatology: Unmatched testing expertise
• A family's journey with an ultra-rare disease: Isabel the incredible

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent news and updates. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer, to explore digital advances in clinical diagnostics.

• AI systems for healthcare guidance (00:36): Learn how patients and consumers are using AI tools to better understand their health information.
• Diagnostic’s digital innovation journey (07:43): Explore the evolution of digital advances, their impact on care today, and what lies ahead.
• Guidance for selecting new tools (20:51): Gain practical guidance on selecting new digital tools in the laboratory.

Note: Information in this post was accurate at the time of its posting.

Resources

• From Intake to Interpretation: How AI Assists Lab Teams Today
• Making the Promise of AI a Reality in Laboratory Medicine and Pathology

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to share industry updates and Mayo Clinic’s test development success in 2025. Later, Dr. Pritt welcomes Janelle Santos, M.D., a maternal-fetal medicine specialist at Mayo Clinic, to discuss how she uses a preeclampsia test to care for her patients.

• Public policy insights for 2026 (00:34): Dr. Bill Morice shares insights on reimbursement and AI-related policy developments following an association meeting in Washington, D.C.
• An unprecedented year for test development (04:45): Discover how Mayo Clinic’s record year for test development delivers value to Mayo Clinic’s patients and Mayo Clinic Laboratories’ clients.
• Novel preeclampsia testing (08:13): Learn how new clinical testing helps physicians improve outcomes for women at risk for preeclampsia and their babies.

Note: Information in this post was accurate at the time of its posting.

Resources

• 4 steps to establishing a new approach to innovation
• Innovation beyond the bench: Translating science into better diagnostics and outcomes
• Preeclampsia: Empowering confident decision-making through preeclampsia risk assessment
• Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.
• Preeclampsia sFlt-1/PIGF Ratio, Serum (Mayo ID: PERA)